Is the use of University of Wisconsin solution with prolonged ischemia time an option in clinical liver transplantation?
Nuño
J
J
Liver Transplant Unit, Clínica Puerta de Hierro, Madrid, Spain.
Cuervas-Mons
V
V
Vicente
E
E
Turrión
V
V
Pereira
F
F
Mora
N P
NP
Barrios
C
C
Millán
I
I
Ardaiz
J
J
D000241:Adenosine; D000328:Adult; D000493:Allopurinol; D005260:Female; D005978:Glutathione; D006801:Humans; D007328:Insulin; D007511:Ischemia; D008099:Liver / Q000098:blood supply*; D016031:Liver Transplantation / Q000379:methods* / Q000401:mortality / Q000502:physiology; D008297:Male; D009017:Morbidity; D009926:Organ Preservation / Q000379:methods*; D019188:Organ Preservation Solutions; D011183:Postoperative Complications / Q000453:epidemiology*; D011887:Raffinose; D012189:Retrospective Studies
D007328:Insulin; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D000493:Allopurinol; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose